Research Areas

Phase 3 human clinical trials of Malaria

Bone and Soft Tissue Regeneration

Development of new therapies for malaria

Design of ligand-targeted drugs

Tumor-targeted dyes for fluorescence-guided surgery of cancer

Reprogramming of the Human Immune System

Fluorescence Guided Surgery of Cancer

Design of new therapies for sickle cell disease

Design of targeted anti-viral therapies

Targeted control of cell-based therapeutics

Drug targeting to the tumor microenvironment

Structural characterization of the human red blood cell membrane

Pharmacologic control of neurotransmitter transporters

Radioligand therapies for cancer

SYK-specific tyrosine kinase inhibitors

RNA and DNA-based therapeutics

Therapies for Liver Diseases

Therapies for Fibrotic Diseases